NGF and plasma cell myeloma: However, MRD assessment was performed in bone marrow samples using NGF, and patients were neither tested for myeloma disease distribution using positron emission tomography/computerized tomography (PET/CT) or magnetic resonance imaging (MRI) [69,75,76] nor for M-protein levels using mass spectrometry [77,78,79,80].